Bioctogen is a Biotech CRO offering Immuno-Oncology drug validation services that rely on independently-developed humanized immune-checkpoint mouse models (e.g. B-hPD-1 mice) and immune-deficient mouse model (B-NDG mouse). Biocytogen also offers human antibody mouse models (RenMab Mouse), CDX models, PDX models, in vivo and in vitro efficacy services, PK/PD study services, ect. We also provide customized models generated by our gene targeting platform, featuring CRISPR-based EGE® technology, which increases large fragment knockin efficiency by 10-20-fold. Learn more at www.biocytogen.com.
There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.